- Home
- ROIV vs HRB Comparison
ROIV vs HRB Comparison
Compare ROIV & HRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- HRB
- Stock Information
- Founded
- ROIV 2014
- HRB 1955
- Country
- ROIV United Kingdom
- HRB United States
- Employees
- ROIV N/A
- HRB N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- HRB Other Consumer Services
- Sector
- ROIV Health Care
- HRB Consumer Discretionary
- Exchange
- ROIV Nasdaq
- HRB Nasdaq
- Market Cap
- ROIV 8.4B
- HRB 8.3B
- IPO Year
- ROIV N/A
- HRB N/A
- Fundamental
- Price
- ROIV $11.83
- HRB $56.85
- Analyst Decision
- ROIV Strong Buy
- HRB Sell
- Analyst Count
- ROIV 9
- HRB 2
- Target Price
- ROIV $17.69
- HRB $57.00
- AVG Volume (30 Days)
- ROIV 4.5M
- HRB 1.5M
- Earning Date
- ROIV 11-12-2024
- HRB 11-07-2024
- Dividend Yield
- ROIV N/A
- HRB 2.61%
- EPS Growth
- ROIV N/A
- HRB 13.55
- EPS
- ROIV 5.89
- HRB 4.11
- Revenue
- ROIV $129,128,999.00
- HRB $3,620,357,000.00
- Revenue This Year
- ROIV $48.37
- HRB $4.01
- Revenue Next Year
- ROIV $13.76
- HRB $2.64
- P/E Ratio
- ROIV $2.01
- HRB $13.97
- Revenue Growth
- ROIV 145.68
- HRB 4.15
- 52 Week Low
- ROIV $8.61
- HRB $42.28
- 52 Week High
- ROIV $13.06
- HRB $68.45
- Technical
- Relative Strength Index (RSI)
- ROIV 51.97
- HRB 39.13
- Support Level
- ROIV $11.05
- HRB $55.08
- Resistance Level
- ROIV $12.05
- HRB $60.49
- Average True Range (ATR)
- ROIV 0.30
- HRB 1.71
- MACD
- ROIV -0.02
- HRB -0.40
- Stochastic Oscillator
- ROIV 61.86
- HRB 20.22
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About HRB H&R Block Inc.
H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public primarily in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives most of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively significant.